Emerging treatments

Insulin human inhalation powder

Rapid-acting inhaled insulin delivered through the lungs has again been approved by the US Food and Drug Administration (FDA) for use in diabetes. A previous inhaled insulin product was removed from the market, with FDA-mandated screening of users of that earlier inhaled insulin product for lung cancer. Inhaled insulin is not preferred over injectable insulins with more established safety experience.

Use of this content is subject to our disclaimer